October 28, 2013
The Japanese Society of Hypertension (JSH) said that it received on October 8 a notice of withdrawal from Hiroaki Matsubara, the chief investigator of the KYOTO Heart Study on Novartis Pharma’s hypertension drug Diovan (valsartan) whose data were later determined...read more